39259845|t|The Antiproteinopathy, Antioxidant, and Antiapoptotic Effects of Methylene Blue and 4-Phenylbutyric Acid Alone, and in Combination on Familial Alzheimer's Disease PSEN1 I416T Cholinergic-Like Neurons.
39259845|a|Familial Alzheimer's disease (FAD) is a chronic neurological condition that progresses over time. Currently, lacking a viable treatment, the use of multitarget medication combinations has generated interest as a potential FAD therapy approach. In this study, we examined the effects of 4-phenylbutyric acid (4-PBA) and methylene blue (MB) either separately or in combination on PSEN1 I416T cholinergic-like neuron cells (ChLNs), which serve as a model for FAD. We found that MB was significantly efficient at reducing the accumulation of intracellular Abeta, phosphorylation of TAU Ser202/Thr205, and increasing Deltapsim, whereas 4-PBA was significantly efficient at diminishing oxidation of DJ-1Cys106-SH, expression of TP53, and increasing ACh-induced Ca2+ influx. Both agents were equally effective at blunting phosphorylated c-JUN at Ser63/Ser73 and activating caspase 3 (CASP3) into cleaved caspase 3 (CC3) on mutant cells. Combination of MB and 4-PBA at middle (0.1, 1) concentration significantly reduced iAbeta, p-TAU, and oxDJ-1 and augmented the ACh-induced Ca2+ influx compared to combined agents at low (0.05, 0.5) or high (0.5, 5) concentration. However, combined MB and 4-PBA were efficient only at dropping DJ-1Cys106-SO3 and increasing ACh-induced Ca2+ inward in mutant ChLNs. Our data show that the reagents MB and 4-PBA alone possess more than one action (e.g., antiamyloid, antioxidant, anti-TAU, antiapoptotic, and ACh-induced Ca2+ influx enhancers), that in combination might cancel or diminish each other. Together, these results strongly argue that MB and 4-PBA might protect PSEN1 I416T ChLNs from Abeta-induced toxicity by working intracellularly as anti-Abeta and anti-Tau agents, improving Deltapsim and cell survival, and extracellularly, by increasing ACh-induced Ca2+ ion influx. MB and 4-PBA are promising drugs with potential for repurposing in familial AD.
39259845	4	21	Antiproteinopathy	Disease	
39259845	65	79	Methylene Blue	Chemical	MESH:D008751
39259845	84	110	4-Phenylbutyric Acid Alone	Chemical	-
39259845	134	162	Familial Alzheimer's Disease	Disease	MESH:D000544
39259845	163	168	PSEN1	Gene	5663
39259845	169	174	I416T	ProteinMutation	tmVar:p|SUB|I|416|T;HGVS:p.I416T;VariantGroup:0;CorrespondingGene:4137;RS#:149471977;CorrespondingSpecies:9606;CA#:8617909
39259845	201	229	Familial Alzheimer's disease	Disease	MESH:D000544
39259845	231	234	FAD	Disease	MESH:D000544
39259845	249	271	neurological condition	Disease	MESH:D019636
39259845	423	426	FAD	Disease	MESH:D000544
39259845	487	507	4-phenylbutyric acid	Chemical	MESH:C075773
39259845	509	514	4-PBA	Chemical	MESH:C075773
39259845	520	534	methylene blue	Chemical	MESH:D008751
39259845	536	538	MB	Chemical	MESH:D008751
39259845	579	584	PSEN1	Gene	5663
39259845	585	590	I416T	ProteinMutation	tmVar:p|SUB|I|416|T;HGVS:p.I416T;VariantGroup:0;CorrespondingGene:4137;RS#:149471977;CorrespondingSpecies:9606;CA#:8617909
39259845	657	660	FAD	Disease	MESH:D000544
39259845	676	678	MB	Chemical	MESH:D008751
39259845	753	758	Abeta	Gene	351
39259845	779	782	TAU	Gene	4137
39259845	832	837	4-PBA	Chemical	MESH:C075773
39259845	923	927	TP53	Gene	7157
39259845	944	947	ACh	Chemical	MESH:D000109
39259845	956	960	Ca2+	Chemical	-
39259845	1031	1036	c-JUN	Gene	3725
39259845	1067	1076	caspase 3	Gene	836
39259845	1078	1083	CASP3	Gene	836
39259845	1098	1107	caspase 3	Gene	836
39259845	1146	1148	MB	Chemical	MESH:D008751
39259845	1153	1158	4-PBA	Chemical	MESH:C075773
39259845	1224	1227	TAU	Gene	4137
39259845	1258	1261	ACh	Chemical	MESH:D000109
39259845	1270	1274	Ca2+	Chemical	-
39259845	1379	1381	MB	Chemical	MESH:D008751
39259845	1386	1391	4-PBA	Chemical	MESH:C075773
39259845	1424	1438	DJ-1Cys106-SO3	Chemical	-
39259845	1454	1457	ACh	Chemical	MESH:D000109
39259845	1466	1470	Ca2+	Chemical	-
39259845	1527	1529	MB	Chemical	MESH:D008751
39259845	1534	1539	4-PBA	Chemical	MESH:C075773
39259845	1582	1593	antiamyloid	Chemical	-
39259845	1613	1616	TAU	Gene	4137
39259845	1637	1640	ACh	Chemical	MESH:D000109
39259845	1649	1653	Ca2+	Chemical	-
39259845	1774	1776	MB	Chemical	MESH:D008751
39259845	1781	1786	4-PBA	Chemical	MESH:C075773
39259845	1801	1806	PSEN1	Gene	5663
39259845	1807	1812	I416T	ProteinMutation	tmVar:p|SUB|I|416|T;HGVS:p.I416T;VariantGroup:0;CorrespondingGene:4137;RS#:149471977;CorrespondingSpecies:9606;CA#:8617909
39259845	1824	1829	Abeta	Gene	351
39259845	1838	1846	toxicity	Disease	MESH:D064420
39259845	1882	1887	Abeta	Gene	351
39259845	1897	1900	Tau	Gene	4137
39259845	1983	1986	ACh	Chemical	MESH:D000109
39259845	1995	2003	Ca2+ ion	Chemical	-
39259845	2012	2014	MB	Chemical	MESH:D008751
39259845	2019	2024	4-PBA	Chemical	MESH:C075773
39259845	2088	2090	AD	Disease	MESH:D000544
39259845	Cotreatment	MESH:C075773	MESH:D008751
39259845	Association	MESH:D000544	RS#:149471977;HGVS:p.I416T;CorrespondingGene:4137
39259845	Negative_Correlation	MESH:D008751	RS#:149471977;HGVS:p.I416T;CorrespondingGene:4137
39259845	Negative_Correlation	MESH:D008751	351
39259845	Negative_Correlation	MESH:C075773	3725
39259845	Negative_Correlation	MESH:D008751	MESH:D000544
39259845	Positive_Correlation	MESH:C075773	836
39259845	Negative_Correlation	MESH:D008751	4137
39259845	Negative_Correlation	MESH:C075773	4137
39259845	Positive_Correlation	MESH:D008751	836
39259845	Negative_Correlation	MESH:C075773	MESH:D000544
39259845	Negative_Correlation	MESH:C075773	7157
39259845	Positive_Correlation	MESH:C075773	MESH:D000109
39259845	Negative_Correlation	MESH:D064420	351
39259845	Positive_Correlation	MESH:D000109	MESH:D008751
39259845	Association	MESH:D000544	4137

